Clinical Trial Update: An Exploratory Trial Investigating the Neurogenic Component in Psoriasis Vulgaris by Use of Botulinum Toxin A [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 exploratory trial investigating botulinum toxin A for the neurogenic component of psoriasis vulgaris, sponsored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 1 | Status: COMPLETED